All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F21%3A10432436" target="_blank" >RIV/00064203:_____/21:10432436 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11130/21:10432436

  • Result on the web

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=aOSFxpXWFN" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=aOSFxpXWFN</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1038/s41431-021-00859-0" target="_blank" >10.1038/s41431-021-00859-0</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

  • Original language description

    For the first time in Europe hundreds of rare disease (RD) experts team up to actively share and jointly analyse existing patient&apos;s data. Solve-RD is a Horizon 2020-supported EU flagship project bringing together &gt;300 clinicians, scientists, and patient representatives of 51 sites from 15 countries. Solve-RD is built upon a core group of four European Reference Networks (ERNs; ERN-ITHACA, ERN-RND, ERN-Euro NMD, ERN-GENTURIS) which annually see more than 270,000 RD patients with respective pathologies. The main ambition is to solve unsolved rare diseases for which a molecular cause is not yet known. This is achieved through an innovative clinical research environment that introduces novel ways to organise expertise and data. Two major approaches are being pursued (i) massive data re-analysis of &gt;19,000 unsolved rare disease patients and (ii) novel combined -omics approaches. The minimum requirement to be eligible for the analysis activities is an inconclusive exome that can be shared with controlled access. The first preliminary data re-analysis has already diagnosed 255 cases form 8393 exomes/genome datasets. This unprecedented degree of collaboration focused on sharing of data and expertise shall identify many new disease genes and enable diagnosis of many so far undiagnosed patients from all over Europe. (C) 2021, The Author(s).

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30101 - Human genetics

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2021

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    European Journal of Human Genetics

  • ISSN

    1018-4813

  • e-ISSN

  • Volume of the periodical

    29

  • Issue of the periodical within the volume

    9

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    7

  • Pages from-to

    1325-1331

  • UT code for WoS article

    000656824000001

  • EID of the result in the Scopus database

    2-s2.0-85107583586